Chevy Chase Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $159M | Buy |
205,833
+5,086
| +3% | +$3.89M | 0.46% | 36 |
|
|
2025
Q4 | $155M | Sell |
200,747
-2,405
| -1% | -$1.63M | 0.42% | 38 |
|
|
2025
Q3 | $114M | Sell |
203,152
-3,576
| -2% | -$2.02M | 0.31% | 61 |
|
|
2025
Q2 | $109M | Sell |
206,728
-14,482
| -7% | -$8.08M | 0.32% | 59 |
|
|
2025
Q1 | $140M | Sell |
221,210
-8,557
| -4% | -$5.89M | 0.45% | 38 |
|
|
2024
Q4 | $164M | Sell |
229,767
-8,612
| -4% | -$7.23M | 0.5% | 34 |
|
|
2024
Q3 | $251M | Sell |
238,379
-3,375
| -1% | -$3.76M | 0.77% | 18 |
|
|
2024
Q2 | $254M | Sell |
241,754
-626
| -0.3% | -$607K | 0.81% | 17 |
|
|
2024
Q1 | $233M | Sell |
242,380
-7,197
| -3% | -$6.84M | 0.76% | 19 |
|
|
2023
Q4 | $219M | Sell |
249,577
-1,344
| -0.5% | -$1.11M | 0.78% | 18 |
|
|
2023
Q3 | $206M | Sell |
250,921
-1,811
| -0.7% | -$1.42M | 0.82% | 18 |
|
|
2023
Q2 | $182M | Sell |
252,732
-1,736
| -0.7% | -$1.34M | 0.68% | 25 |
|
|
2023
Q1 | $209M | Sell |
254,468
-3,666
| -1% | -$2.76M | 0.83% | 17 |
|
|
2022
Q4 | $186M | Sell |
258,134
-22,210
| -8% | -$16.4M | 0.79% | 21 |
|
|
2022
Q3 | $193M | Buy |
280,344
+14,881
| +6% | +$9.37M | 0.82% | 19 |
|
|
2022
Q2 | $157M | Buy |
265,463
+15,428
| +6% | +$10M | 0.65% | 29 |
|
|
2022
Q1 | $175M | Buy |
250,035
+18,161
| +8% | +$11.5M | 0.6% | 30 |
|
|
2021
Q4 | $146M | Buy |
231,874
+10,618
| +5% | +$6.53M | 0.47% | 42 |
|
|
2021
Q3 | $134M | Buy |
221,256
+40,261
| +22% | +$25M | 0.47% | 45 |
|
|
2021
Q2 | $101M | Buy |
180,995
+11,658
| +7% | +$5.91M | 0.34% | 64 |
|
|
2021
Q1 | $80.1M | Buy |
169,337
+32,207
| +23% | +$15.7M | 0.29% | 86 |
|
|
2020
Q4 | $66.3M | Sell |
137,130
-4,915
| -3% | -$2.65M | 0.24% | 97 |
|
|
2020
Q3 | $79.5M | Buy |
142,045
+8,664
| +6% | +$5.25M | 0.31% | 78 |
|
|
2020
Q2 | $83.2M | Buy |
133,381
+47,978
| +56% | +$27.2M | 0.34% | 70 |
|
|
2020
Q1 | $41.7M | Buy |
85,403
+1,110
| +1% | +$458K | 0.19% | 121 |
|
|
2019
Q4 | $31.7M | Sell |
84,293
-3,142
| -4% | -$1.06M | 0.12% | 184 |
|
|
2019
Q3 | $24.3M | Sell |
87,435
-37,187
| -30% | -$11M | 0.1% | 218 |
|
|
2019
Q2 | $39M | Sell |
124,622
-24,106
| -16% | -$8.03M | 0.16% | 143 |
|
|
2019
Q1 | $51.6M | Buy |
148,728
+29,030
| +24% | +$12M | 0.21% | 109 |
|
|
2018
Q4 | $44.7M | Buy |
119,698
+13,242
| +12% | +$4.85M | 0.22% | 106 |
|
|
2018
Q3 | $43M | Buy |
106,456
+4,600
| +5% | +$1.75M | 0.18% | 130 |
|
|
2018
Q2 | $35.1M | Buy |
101,856
+2,571
| +3% | +$804K | 0.15% | 155 |
|
|
2018
Q1 | $34.2M | Sell |
99,285
-3,338
| -3% | -$1.16M | 0.15% | 158 |
|
|
2017
Q4 | $38.6M | Sell |
102,623
-26,896
| -21% | -$10.9M | 0.17% | 142 |
|
|
2017
Q3 | $57.9M | Buy |
129,519
+33,800
| +35% | +$16.1M | 0.26% | 99 |
|
|
2017
Q2 | $47M | Buy |
95,719
+23,553
| +33% | +$10.3M | 0.23% | 111 |
|
|
2017
Q1 | $28M | Buy |
72,166
+2,728
| +4% | +$1.01M | 0.14% | 177 |
|
|
2016
Q4 | $25.5M | Buy |
69,438
+213
| +0.3% | +$81K | 0.14% | 179 |
|
|
2016
Q3 | $27.8M | Sell |
69,225
-3,626
| -5% | -$1.45M | 0.15% | 159 |
|
|
2016
Q2 | $25.4M | Buy |
72,851
+833
| +1% | +$321K | 0.14% | 167 |
|
|
2016
Q1 | $26M | Buy |
72,018
+7,798
| +12% | +$3.21M | 0.15% | 158 |
|
|
2015
Q4 | $34.9M | Buy |
64,220
+681
| +1% | +$369K | 0.2% | 119 |
|
|
2015
Q3 | $29.6M | Buy |
63,539
+3,724
| +6% | +$2M | 0.18% | 133 |
|
|
2015
Q2 | $30.5M | Buy |
59,815
+2,029
| +4% | +$990K | 0.18% | 144 |
|
|
2015
Q1 | $26.1M | Buy |
57,786
+1,519
| +3% | +$644K | 0.16% | 163 |
|
|
2014
Q4 | $23.1M | Sell |
56,267
-136
| -0.2% | -$53.5K | 0.14% | 177 |
|
|
2014
Q3 | $20.3M | Sell |
56,403
-771
| -1% | -$258K | 0.13% | 186 |
|
|
2014
Q2 | $16.1M | Sell |
57,174
-456
| -0.8% | -$135K | 0.11% | 209 |
|
|
2014
Q1 | $17.3M | Buy |
57,630
+193
| +0.3% | +$59.5K | 0.12% | 198 |
|
|
2013
Q4 | $15.8M | Buy |
57,437
+1,118
| +2% | +$322K | 0.12% | 202 |
|
|
2013
Q3 | $17.6M | Buy |
56,319
+2,459
| +5% | +$647K | 0.14% | 170 |
|
|
2013
Q2 | $12.1M | Buy |
+53,860
| New | +$12.5M | 0.11% | 221 |
|
Other funds holding REGN
VCM
N
Chevy Chase Trust's REGN Position: Q1 2026 in Review
Chevy Chase Trust increased its Regeneron Pharmaceuticals (REGN) stake by 2.5% in Q1 2026, buying an estimated $3.89M and bringing the position to 205,833 shares worth $159M. The position accounts for 0.46% of the portfolio, ranked #36.
Chevy Chase Trust first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $254M in Q2 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Chevy Chase Trust held 205,833 shares of Regeneron Pharmaceuticals worth $159M as of Q1 2026.
- Chevy Chase Trust bought 5,086 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $3.89M.
- Regeneron Pharmaceuticals made up 0.46% of Chevy Chase Trust's portfolio in Q1 2026, its #36 holding.
- Chevy Chase Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Chevy Chase Trust's Regeneron Pharmaceuticals position peaked at $254M in Q2 2024.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.